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Ariiino acid and glucose metabolism was studied in 9 awake dogs in the postabsorp- 
tive state and after the ingestion of 0.7 gm/kg body wt of the amino 
(R) 
acid mixture Freamine II' ' . In the postabsorptive state, there was no 
net exchange of branched chain amino acids (BCAA) across the hepatic or 
extrahepatic splanchnic (EHS) tissues. Alanine was produced by the EHS 
tissues (1.8±0.8 ymoles/min-kg) and removed by the liver (4.8±0.7 pmoles/ 
min«kg). For the other gluconeogenic amino acids, there was a net aver¬ 
age flux of 6.2 ymoles/min*kg of amino acid nitrogen from the peripheral 
to the splanchnic tissues. Glucose was removed by the EHS tissues (0.8 
±0.1 mg/min*kg) and produced by the hepatic tissues (2.9±0.3 mg/min«kg). 
Following ingestion, there was prompt intestinal absorption as re¬ 
flected by the rapidly rising portal concentrations and EHS release of 
all amino acids present in the Freamine II' ' mixture. Over the 3 hr 
study, 100% of the ingested gluconeogenic amino acids and 80% of the BCAA 
were recovered in the portal blood. Cumulative EHS release of alanine 
exceeded the ingested dose by 47%, reflecting continued intestinal pro¬ 
duction of this amino acid in the fed state. The liver removed a total 
of 1736±166 ymoles/kg of alanine, a quantity threefold greater than the 
ingested dose and twofold greater than the net EHS alanine release, which 
comprises both the ingested load and the postcibal intestinal production 
of alanine. Net splanchnic alanine uptake was significant at all times 
and, in association with rising arterial levels, reflects stimulation of 
peripheral alanine production in the fed state. The hepatic uptake of 
other gluconeogenic amino acids was essentially equal to the ingested 
load of these amino acids. 44% of the absorbed BCAA was removed by the 
liver, while the remainder escaped the splanchnic bed to the periphery. 
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Over the 3 hr study, the net flux of gluconeogenic amino acids from the 
peripheral to the splanchnic tissues exceeded the splanchnic escape of 
BCAA by 890 ymoles/kg*3 hrs. 
Hepatic and net splanchnic production, and intestinal removal of 
glucose were significantly stimulated after amino acid ingestion. De¬ 
spite this, plasma arterial glucose levels dropped 7 mg/dl below basal 
by the study's end. In ^ dogs, total body glucose turnover was measured iso- 
topically using 3H-3-glucose. Although the rate of glucose appearance 
(Ra), disappearance (Rd), and metabolic clearance (MCR) all rose after 
feeding, the rise in Rd exceeded that in Ra, resulting in a fall in ar¬ 
terial glucose levels. Mean portal glucagon levels rose 2h fold and re¬ 
mained persistently elevated for the duration of the study. Mean portal 
and arterial insulin rose significantly but returned to baseline levels 
by 90 min. 
Amino acid and glucosemetabolism was also studied in dogs receiving a : 
i R) primed-continuous infusion of Freamine IT . Five dogs received a low- 
dose infusion (0.7 gm/kg), a dose equivalent to that administered in the 
oral studies, and 5 dogs received a high-dose infusion (1.4 gm/kg). Over 
the 3 hr low-dose and high-dose infusions, the liver removed quantities 
of alanine and other gluconeogenic amino acids which equalled or exceeded 
their infused loads, but there was no significant change in the handling 
of these amino acids by the EHS tissues. During the high-dose infusions, 
the hepatic and EHS tissues removed comparable quantities of BCAA and 
together metabolized 973±253 ymoles/kg or 37% of the administered load 
of these amino acids. Over the 3 hr high-dose infusion, the splanchnic 
tissues metabolized 51 ymoles/kg'min of administered amino acids, while 
the peripheral tissues removed 7 ymoles/kg*min, the latter quantity 
hr 
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clearly inadequate to replenish muscle nitrogen stores. The hepatic 
extraction ratios for all amino acids rose during the low and high-dose 
infusions,^as following oral ingestion, and their values were strikingly 
similar in all 3 groups of dogs. The effect of parenterally administered 
amino acids on glucose metabolism and insulin and glucagon levels was 
very similar to that observed following oral ingestion.. 
It is concluded that, following ingestion of an amino acid mixture, 
(1) there is quantitative recovery in the portal blood of nearly all the 
ingested amino acids; (2) peripheral production of alanine is stimulated, 
while intestinal production continues at a rate similar to that observed 
in the postabsorptive state; (3) the liver removes a significant percent¬ 
age of the ingested BCAA, the remainder escaping from the splanchnic bed to 
the periphery; (4) net postabsorptive flux of amino acid nitrogen from 
the peripheral to the splanchnic tissues persists in the fed state; (5) 
insulin and glucagon levels and the rates of hepatic production and 
peripheral uptake of glucose all rise, and there is a small fall in ar¬ 
terial glucose levels. 
Following intravenous amino acid administration, (1) the splanchnic 
bed plays a pivotal role in amino acid disposal; (2) the liver removes 
gluconeogenic and branched chain amino acids, while the EHS tissues me¬ 
tabolize only the BCAA; (3) only a small percentage of the infused load 
is metabolized by peripheral tissues, a quantity inadequate to replenish 
muscle nitrogen stores; (4) hepatic extraction of amino acids is inde¬ 
pendent of the route of their administration. 
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INTRODUCTION 
I. Amino Acid Exchange 1n the Postabsorptive State 
It has long been suspected that muscle, the body's primary re¬ 
pository of protein, and the liver, its repository of urea cycle en¬ 
zymes and major site of amino acid degradation, play a critical role 
in the maintenance of the relatively constant amino acid concentra¬ 
tions that persist in the postabsorptive state (i.e., following a 12- 
14 hour fast) in man. 
Muscle. Release of amino acids by skeletal muscle in man in 
the postabsorptive state was first documented by London et al (1), 
who noted consistently negative arteriovenous differences for 11 of 
16 amino acids across the deep venous bed of the human forearm. Out¬ 
put of alanine and glutamine exceeded that of all other amino acids, 
and alanine accounted for 30% of the total alpha amino nitrogen re¬ 
lease (2). Pozefsky, et al (3), confirmed the primacy of alanine in 
peripheral amino acid release and found a correlation between net 
skeletal muscle output and ambient arterial concentrations of mea¬ 
sured amino acids. Since alanine comprises no more than 10% of 
skeletal muscle tissue (2), it was postulated that alanine release 
reflects not only protein degradation, but de-novo synthesis of 
alanine by transamination of pyruvate. While most amino acids, in¬ 
cluding the branched chain amino acids (BCAA) - leucine, valine, and 
isoleucine- exhibit a net release from muscle in the postabsorptive 
state, glutamate and cystine were consistently taken up (4). 
Splanchnic Tissues. Since the portal vein is inaccessible to 
catheterization in normal man, there have been few studies directly 




amino acids. Assessment of the contribution of the splanchnic bed 
as a whole, i.e., the hepatic and extrahepatic splanchnic tissues 
(spleen, pancreas, and upper intestinal tract), has principally in¬ 
volved the measurement of arterial-hepatic venous (A-HV) differences 
(5, 6). These studies have shown that,for the most part, splanchnic 
uptake of amino acids closely complements their skeletal muscle re¬ 
lease. Alanine and glutamine contribute most prominently to splanch¬ 
nic amino acid uptake, and alanine alone accounts for half of the 
total extraction. The BCAA, however, shows no consistent splanch¬ 
nic uptake. 
Studies of arterial-portal venous differences in human subjects 
catheterized while undergoing elective cholecystectomy (7, 8) and in 
experimental animals (2, 9) have shed light on the individual roles 
of the various splanchnic tissues in amino acid metabolism in the 
postabsorptive state. These studies have revealed that the gut re¬ 
leases substantial quantities of glucogenic amino acids and that its 
output of alanine is nearly equal to the alanine load presented to 
the liver from the periphery. Thus, measurement by A-HV differences 
of the overall splanchnic uptake of alanine had greatly underesti¬ 
mated the true uptake of this amino acid by the liver. In addition, 
these studies showed that the gut, rather than the liver, is solely 
responsible for glutamine uptake by splanchnic tissues. Studies in 
rats (10, 11, 12) have since identified glutamine and ketone bodies 
as the major respiratory fuels of the postabsorptive intestine. Fur¬ 
thermore, greater than 75% of the nitrogen taken up as glutamine by 
the small intestine can be accounted for by release as alanine and 
ammonia (12). There is no consistent uptake by either the liver or 








the intestine of BCAA (6, 7). These findings are in accordance with 
studies in animals (2) which suggest that extrahepatic tissues are 
the major sites of BCAA catabolism. Finally, in the postabsorptive 
state in man, the net alpha amino nitrogen balance across muscle is 
negative, there being a net flux of amino acids to the splanchnic 
region (4, 7, 19). 
Other Tissues. The other major organs in man which contribute 
significantly to amino acid metabolism are the kidney and liver. In 
the postabsorptive state in man, the kidney extracts glutamine as a 
source of nitrogen for ammoniagenesis, a process greatly accelerated 
during acidosis (13). It also releases alanine at a rate which is 10-20% of 
that found in muscle. The brain in the postabsorptive state extracts 
BCAA, particularly leucine, at a rate which exceeds that of all other 
amino acids (2). In fact, studies with rat tissue slices (14) have 
revealed that brain tissue catabolizes leucine several times more 
rapidly than does skeletal muscle tissue. However, since skeletal 
muscle constitutes 43% of the body's mass whereas the brain represents 
only 1%, muscle is probably the major site of BCAA catabolism in 
mammals (14). 
II. The Effect of Protein Ingestion on Amino Acid Metabolism 
That a protein meal is followed by an increase in the concen¬ 
tration of total circulating free amino acids was first shown by Van 
Slyke and Meyer (15) in 1912 in their experiments on dogs. With the 
advent of ion-exchange chromatography. Frame (16) quantitated free 
amino acid levels in humans after ingestion of 60 g of a high pro¬ 
tein meal and found that, although most of the amino acids increased 
in concentration after the meal, the rises did not parallel the rel- 
I 
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ative amino acid composition of the food. Most marked was the rise 
in the BCAA-valine, leucine, and isoleucine - levels of which re¬ 
mained elevated for 8 hr. after ingestion. Several studies in ani¬ 
mals (9, 17, 18, 19) and man (20) have since underscored the unique 
tendency of these amino acids to escape splanchnic metabolism and to 
increase in arterial concentration after amino acid ingestion. Wah- 
ren et al (20) studied splanchnic and leg exchange of amino acids 
in seven healthy human subjects after the ingestion of a protein- 
rich meal. They found that, although there was a release of all 
amino acids from the splanchnic bed after the meal, the BCAA, which 
constituted only 20% of the amino acid residues in the meal (21), 
together accounted for more than half of the total splanchnic out¬ 
put over the three hours post-ingestion. Leg exchange for most amino 
acids reverted from a net release in the postabsorptive state to a 
net uptake after ingestion. Complementing the prominence of the 
BCAA in their escape from the splanchnic bed and rise in arterial 
concentration (100-200% above basal) was their striking uptake by 
the leg, accounting for greater than half of the total peripheral 
amino acid extraction after the meal. This finding confirmed that 
of Aoki et al (22), who studied amino acid metabolism across the 
forearm of a nitrogen-depleted subject after a protein meal and 
similarly found the BCAA to predominate among amino acids extracted 
by muscle. 
Wahren et al (20) found, furthermore, that alanine and gluta¬ 
mine were unique among amino acids in their consistent net splanch¬ 
nic uptake as well as in their persistent peripheral release after 
protein ingestion. The aforementioned studies suggested a unique 
) 
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role for the BCAA in muscle nitrogen repletion after protein inges¬ 
tion. Furthermore, inasmuch as BCAA constitute only 20% of muscle 
amino acids (22) but the majority of protein-induced peripheral 
amino acid uptake, it has been proposed that, in addition to being 
incorporated into muscle protein, they are locally catabolized and 
serve as the major source of nitrogen for the glucose-alanine cycle 
(7, 22, 23, 24), discussed below. Finally, Wahren et al (20) found 
that, despite the splanchnic release of BCAA to the periphery, there 
was a net flux of amino acid nitrogen from muscle to the splanchnic 
tissues during the 3 hours following protein ingestion, Aoki et al 
(76) studied amino acid exchange across the splanchnic bed and fore¬ 
arm of four healthy human subjects after the ingestion of ground 
sirloin. Their findings were strikingly similar to those of Wahren 
et al (20). 
Due to the inaccessibility of the portal vein to catheteriza¬ 
tion in man, there is no data on the individual roles of the liver 
and intestine in the handling of an amino acid meal. However, 
studies in chronically catherized dogs (9), rats (17), and sheep 
(18) fed protein meals have furthered our understanding of their 
functions in the fed state. Several aspects of the disposal of a 
protein meal were consistently observed in all three species. In¬ 
testinal output of alanine exceeded that of all other amino acids. 
Gut release of BCAA greatly exceeded its extraction by the liver, 
resulting in a net splanchnic release to the periphery. The liver 
largely removed most other amino acids added to the portal blood, 
and thus prevented significant net splanchnic release of these sub¬ 




20-30% of the ingested meal (2), appeared in only negligible quanti¬ 
ties in the portal circulation. Also, a large portion of ingested glu¬ 
tamine was metabolized by the portal-drained viscera,, Studies in 
fed rats (11) have since confirmed the latter findings, and it has 
been estimated that all dietary aspartate and glutamate and two- 
thirds of the glutamine are metabolized to urea precursors, primari¬ 
ly alanine and ammonia, during intestinal transport. It has been 
postulated that glutamine is preferentially metabolized in the gut 
rather than in the liver, the repository of urea cycle enzymes, due 
to the higher Km of hepatic glutaminase as compared with intestinal 
glutaminase. In addition, intestinal catabolism of ingested aspar¬ 
tate and glutamate, and glutamate derived from glutamine, prevents 
access of these neurotoxic (11) amino acids to the peripheral circu¬ 
lation. 
The physiologic significance of the aforementioned studies (9, 
17, 18) is uncertain in view of flaws in their experimental design. 
In the rat studies of Yamamoto et al (17), hepatic blood flow was 
not measured so that analysis of amino acid metabolism is qualitative 
rather than quantitative. In addition, the rats were studied while 
anaesthetized, the effects on amino acid metabolism of which are un¬ 
known, Finally, substrate measurements were performed on plasma, 
and studies by Felig et al (8) and Wahren et al (25) have shown that 
blood cellular elements contribute substantially to the interorgan 
transfer of amino acids (discussed below). In the sheep studies of 
Wolff et al (18), too, plasma was used for analysis. In addition, 
sheep, being ruminants, absorb little dietary glucose and depend 
heavily on hepatic gluconeogenesis for glucose production. This pro- 
1 * ", J 
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cess is considered to be greatly stimulated after ingestion of glu¬ 
cogenic amino acids and, thus, the relevance of these studies to non¬ 
ruminant species is uncertain. The studies of Elwyn et al (9) were 
performed on but three animals, and ,within this small group, there were 
significant quantitative and at timesdirectional differences in the inter¬ 
organ movements of the amino acids. 
In their recent studies on dogs, Bloomgarden et al (19) have 
reported a significant correlation between gut output and hepatic 
uptake of amino acids after protein ingestion. They, too, noted a 
predominance of alanine amongst amino acids released from the gut. 
Its quantity exceeded that present in the ingested meal, suggesting 
continued intestinal alanine synthesis in the fed state. Hepatic 
extraction of alanine rose concomitant with the increase in gut out¬ 
put, accounting for its minimal net splanchnic output. Although 
peripheral balances were not measured, the rise in arterial alanine 
concentration despite continued splanchnic uptake suggests persist¬ 
ent peripheral production of alanine in the fed state, confirming 
the findings of Wahren et al (20) in humans. Finally, they noted a 
failure of the liver to take up ingested BCAA, and supported a pure¬ 
ly passive role for the liver in the handling of these amino acids. 
One of the major objectives of the current study was to quanti¬ 
tatively and definitively elucidate the individual roles of the he¬ 
patic and extrahepatic splanchnic tissues in the metabolism of an 
amino acid meal. 
III. The Effect of Protein Ingestion on Glucose Metabolism 
It has been shown that the opposing actions of insulin and 







neogenesis and glucose homeostasis in the basal state (26). In 
addition, it has long been known that there is a rise in both insu¬ 
lin and glucagon secretion after protein ingestion (27, 28). The 
rise in insulin concentration has been proposed as a mechanism for 
facilitating peripheral uptake and utilization of ingested amino 
acids which escape splanchnic metabolism,, Linger et al (29) have 
postulated that the purpose of aminogenic hyperglucagonemia is to 
stimulate hepatic glucose production, thereby preventing a decline 
in blood glucose concentration that would otherwise occur from un¬ 
opposed protein-stimulated insulin secretion during carbohydrate- 
free protein meals. They have demonstrated that when endogenous 
glucagon secretion is suppressed by continuous glucose infusion, hy- 
peraminoacidemia induces a mean maximal fall in glucose concentra¬ 
tion of 35 mg/dl, significantly greater than the 3 mg/dl fall ob¬ 
served when endogenous glucagon production is not suppressed. The 
physiologic importance of aminogenic hyperglucagonemia is uncertain, 
however. 
Wahren et al (20) have studied the effect of protein ingestion 
on splanchnic glucose metabolism in man and have found that in 
healthy subjects both the splanchnic production and the arterial 
concentration of glucose remain essentially unchanged after pro¬ 
tein intake. In addition, they found that protein ingestion re¬ 
sults in a rise in both insulin and glucagon arterial levels. Ear¬ 
lier studies by Felig and Wahren (5) have shown that when increments 
in arterial insulin comparable to those observed after protein in¬ 
gestion (i.e., 60-100% above basal) are induced in normal postab- 
sorptive man by glucose infusion, splanchnic glucose production falls 
•' ' fl 
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by 85%. Their data further suggested that the liver rather than the 
peripheral tissues is the primary target organ whereby glucose homeo¬ 
stasis is achieved with small increments in insulin. The fact that 
decline in splanchnic glucose production did not occur after protein 
ingestion is probably the result of concomitant aminogenic hyperglu- 
cagonemia. In this context, it is of interest to note that when Wah- 
ren et al (20) administered the protein meal to diabetics, there was 
a 150% rise in splanchnic glucose production concomitant with a two¬ 
fold rise in arterial glucagon levels. The authors speculate that 
the absence of a rise in insulin levels after the meal leads to un¬ 
opposed hyperglucagonemia and increased hepatic glucose production 
in these patients. 
The effect of a protein meal on glucose exchange across the 
liver and intestine has never been examined. In the current stud¬ 
ies, this effect was assessed by the organ balance technique (see 
Methods). In addition, the rates of endogenous production, dis¬ 
appearance and metabolic clearance of glucose after protein inges- 
3 
tion were measured isotopically with 3- H-glucose (see Methods). 
IV. Alanine 
A. Its Role As A Gluconeogenic Precursor 
The glucose produced by the liver derives from either glyco- 
genolysis or gluconeogenesis. In the postabsorptive state, 75% of 
hepatic glucose production is the result of glycogen breakdown, 
while 25% is the product of gluconeogenesis (23). Lactate, pyru¬ 
vate, glycerol, and amino acids, predominantly alanine, constitute 
the major substrates for the latter process. Alanine alone accounts 







glycogen stores are depleted, such as after a 24 hour fast (23) or 
prolonged exercise (2, 23), gluconeogenesis assumes primacy as the 
mode of glucose production, and alanine becomes all the more import¬ 
ant as its primary substrate. 
The importance of alanine as a gluconeogenic precursor was 
first suggested by Ross et al (30) who measured the rate of gluco¬ 
neogenesis from all major physiologic precursors in the perfused rat 
liver and found that of the amino acids studied, the rates of glu¬ 
cose production were greatest from alanine, serine and proline. 
Mallette et al (31) subsequently reported that glucose production 
from alanine increased linearly with an increase in its concentra¬ 
tion up to 9 mM or 20 times its normal physiologic concentration. 
Although later in vivo rat studies by Aikawa et al (32) noted linear¬ 
ity up to only 3-4 mM, the catalytic potential of this gluconeogenic 
pathway appears to be quite striking. Felig et al (33) have shown 
that the administration of exogenous alanine to starved, glycogen- 
depleted human subjects resulted in a prompt hyperglycemic response. 
They further showed (34) that human subjects,both in the postabsorp- 
14 tive state and after a prolonged fast, promptly incorporated C 
from administered alanine-^^C into blood glucose with recovery in 
30-60 minutes. On the basis of the above observations and the docu¬ 
mentation of its prominent peripheral release and hepatic extraction 
(discussed above), alanine has been assigned a primary role as a 
gluconeogenic precursor. 
The roles of insulin and glucagon in the regulation of gjuco- 
neogenesis from alanine have been extensively studied in recent 
years by either arterio-hepatic venous (A-HV) catheterization or 
tracer studies (5, 26, 31, 35-43), each technique possessing cer- 
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tain limitations (35). The A-HV catheterization technique provides 
accurate information on the splanchnic extraction rate of various 
gluconeogenic precursors but no information on the fate of the ex¬ 
tracted precursor, i.e., whether it is converted to glucose. With 
the tracer technique, precursor fate can be determined, but, without 
complicated kinetic analysis, quantitative information regarding the 
conversion of precursors to glucose cannot be derived. 
Felig et al (5), employing the A-HV catheterization technique, 
have reported that after glucose infusion in man, there is a rise 
in the arterial insulin level associated with a fall in the splanch¬ 
nic extraction of alanine. They have further suggested that the in¬ 
sulin rise caused a decrease in hepatic alanine extraction with a 
resultant reduction in splanchnic glucose production. Subsequent 
studies by Chiasson et al in dogs (36) and man (37) have demonstra¬ 
ted that, when euglycemia is maintained by variable glucose infusion 
a rise in insulin concentration does not alter splanchnic extraction 
of alanine. The authors have attributed the divergent findings of 
Felig et al (5) to the concomitant hyperglycemia in the latter study 
In this regard, Shulman et al (33) have recently shown in dogs that 
glucose per se, i.e., independent of changes in insulin and glucagon 
secretion, can significantly impair hepatic fractional extraction 
of alanine. In the recent studies of Chiasson (37), a combination 
of the A-HV catheterization and the tracer techniques was employed 
in the assessment of the effects of insulin infusion at two doses on 
gluconeogenesis from alanine. Glucagon was infused for forty min¬ 
utes at the study's end to flush out and quantitate any ^\-glucose 








sion. They found that, after a 48 hour fast, low dose insulin in¬ 
fusion (with a resultant mean arterial insulin of 100 yU/ml) sup¬ 
pressed hepatic glucose production primarily by diverting newly 
synthesized glucose into glycogen while the high dose infusion (421 
uU/ml, mean insulin level) inhibited glucose production by inhib¬ 
iting gluconeogenesis from alanine. 
That glucagon stimulates gluconeogenesis from alanine was 
first demonstrated by Garcia et al (39) and Mallette et al (31) in 
their studies on perfused rat livers. Livers perfused with gluca¬ 
gon showed a high glucose output which was largely a result of 
stimulated glycogenolysis. Chiasson et al (40), using tracer tech¬ 
niques, studied the effect of glucagon on gluconeogenesis in 
anesthetized dogs and found that, after the infusion of glucagon at 
a rate sufficient to produce arterial glucagon levels in the high 
physiologic range, gluconeogenesis from alanine was significantly 
stimulated. Tracer studies by Brockman et al (41) in sheep con¬ 
firmed the stimulatory effect of glucagon on gluconeogenesis from 
alanine and documented a marked increase in hepatic extraction of 
alanine with a concomitant decline in its arterial concentration. 
Jennings et al (26) studied the roles of glucagon and insulin in 
the regulation of gluconeogenesis from alanine in the postabsorp- 
tive anesthetized dog using the tracer technique. By infusing 
somatostatin, a potent inhibitor of both pancreatic hormones, 
alone or in combination with the intraportal replacement infusion 
of either insulin or glucagon, a deficiency of either or both hor¬ 
mones was affected. They found that isolated insulin deficiency 
(basal glucagon levels maintained) caused a 74% increase and iso- 




lated glucagon deficiency (basal insulin levels maintained) a 45% 
decrease in the conversion of alanine to glucose. Isolated defi¬ 
ciency of either hormone did not alter splanchnic extraction of 
alanine. This study demonstrated the existence of a delicate bal¬ 
ance between the inhibitory effect of insulin and the stimulatory 
effect of glucagon in the maintenance of basal gluconeogenesis. It 
furthermore suggests, in contradistinction to earlier studies (5, 
23, 31, 40), that both hormones influence gluconeogenesis from ala¬ 
nine not by altering its hepatic extraction but by regulating its 
intrahepatic metabolism. 
The observation that glucagon production is markedly stimula¬ 
ted in man during states of increased gluconeogenesis (23, 42) has 
suggested that the hormone is an important regulator of the latter 
process in humans. Following a 72 hour fast, for example, alanine 
administration results in an increase in plasma glucose that is pro¬ 
portional to the rise in plasma glucagon (42). Chiasson et al (43), 
combining the A-HV catheterization and the tracer techniques, have 
reported that, in postabsorptive man, after the administration of 
supraphysiologic doses of glucagon, gluconeogenesis from alanine is 
doubled. In addition, hepatic alanine extraction is unaltered, con¬ 
firming their earlier findings in dogs (26) that the hormone exerts 
a purely intrahepatic stimulatory effect on gluconeogenesis. The 
importance of glucagon at physiologic levels in the regulation of 
gluconeogenesis in man remains unresolved. 
B. The Glucose-Alanine Cycle 
Alanine constitutes 7-10% of muscle amino acid residues (2, 
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(2, 3). This led Felig et al (3, 7, 23) and Mallette et al (31) to 
independently postulate that alanine is synthesized de novo in mus¬ 
cle by the transamination of pyruvate, utilizing amino groups gen¬ 
erated by local amino acid degradation. The BCAA, which constitute 
20% of muscle protein but only 10-12% of the amino acid nitrogen re¬ 
leased, were postulated to be the source of the amino groups. It 
was hypothesized that alanine released by skeletal muscle helped to 
transport the toxic ammonia products of BCAA catabolism to the liver 
for disposal as urea while serving as a major gluconeogenic precur¬ 
sor for the liver. Many clinical and biochemical observations have 
since underscored the physiologic importance of the glucose-alanine 
cycle and elucidated the origin of newly synthesized alanine in skel¬ 
etal muscle. 
The origin of the carbon skeleton of alanine released by skel¬ 
etal muscle has been a topic of lively contention for many years. 
Many investigators (21, 45, 49-52), in support of the glucose-ala- 
nine cycle, have postulated that the carbon skeleton is derived al¬ 
most exclusively from glycolysis of exogenous glucose and not from 
amino acids generated by local protein degradation. Others (46-48) 
have suggested that the carbon skeleton is derived primarily from 
local catabolism within the muscle cell with subsequent conversion 
of the carbon skeleton to pyruvate via the tricarboxylic acid (TCA) 
cycle. 
Odessey et al (21) first demonstrated that when ^^C-glucose is 
added to the diaphragms of fasted rats in vitro, at least 60% of the 
alanine contains carbon from the labelled precursor. The addition 
of BCAA increased alanine production two-fold with at least 70% of 
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alanine's carbon coming from labelled exogenous glucose. In addi¬ 
tion, alanine production from fasted rat diaphragms increased upon 
addition of glucose and even further in the presence of insulin. 
The further stimulation with insulin presumably reflected its abil¬ 
ity to facilitate transport and/or metabolism of glucose since by 
itself insulin had no effect on alanine synthesis. The experiments 
of Manchester (49) and Odessey et al (45) on rat diaphragms and 
later studies by Chang and Goldberg (50) on rat soleus and extensor 
14 digitorum showed that, of all amino acids examined, only C-la- 
belled aspartate, glutamate, valine, isoleucine and asparagine were 
14 14 
converted to CO^. The lack of CO2 production from other la¬ 
belled amino acids indicates that they cannot be converted to inter¬ 
mediates in the TCA cycle or to pyruvate in muscle. Thus, only the 
aforementioned five amino acids could theoretically supply the car¬ 
bon skeleton for alanine synthesis. Garber et al (47) and Goldstein 
et al (48) reported that aspartate, cysteine, leucine, valine, meth¬ 
ionine, isoleucine, serine, threonine, glycine all significantly in¬ 
creased the formation and release of alanine from muscle in vitro 
and consequently concluded that the carbon chains from these amino 
acids are used in alanine synthesis. However, these experiments 
were carried out with amino acid concentrations approximately 100 times 
physiologic levels. At physiologic concentrations, their effects 
appear to be insignificant (45, 49-51), 
In order to conclusively settle the controversy regarding the 
origin of alanine's carbon skeleton, Chang et al (50) measured the 
rates of pyruvate generation from exogenous glucose and from rat 
muscle protein breakdown in the rat diaphragm. The rate of glyco- 




lysis was measured by the generation of HOH from exogenous 5- H- 
glucose. The rate of generation from protein breakdown of the five 
amino acids that enter the TCA cycle was estimated from the measured 
rate of tyrosine release and the relative proportion of tyrosine and 
the five amino acids in muscle. The authors concluded that, even if 
all the carbon skeletons from the five amino acids were to be con¬ 
verted to pyruvate, 97% of the carbons used for alanine synthesis in 
muscle must still derive from exogenous glucose rather than from en¬ 
dogenous protein catabolism. Finally, Ben Galim et al (52), in their 
recent in vivo tracer studies on dogs, found that the quantity of 
glucose extracted by the dog hindlimb could generate four times the 
amount of pyruvate necessary to account for the alanine produced, 
confirming the prominent role of glucose-derived pyruvate in alanine 
synthesis. 
That BCAA are peripherally metabolized was first suggested 
by the studies of Miller (44) who noted that labelled valine, leu¬ 
cine, and isoleucine are catabolized at similar rates in normal and 
hepatectomized animals. Subsequently, Odessey and Goldberg, in 
their studies on diaphragms from fed rats using ^^C-labelled amino 
acids (14, 45), demonstrated that the catabolism of the BCAA to CO^ 
proceeds at a rate comparable to their incorporation into muscle 
protein. By contrast, none of the other amino acids was significant¬ 
ly degraded to CO^. Furthermore, in diaphragms from fasted rats, 
oxidation of BCAA increased its production of alanine and glutamine 
in a concentration-dependent manner. The addition of other amino 
acids, even at 2-5 times their normal concentrations, failed to 
stimulate alanine production. 
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Transamination of BCAA occurs almost exclusively with alpha- 
ketoglutarate to form glutamate which may either donate its amino 
group to pyruvate to form alanine or incorporate free ammonia to 
form glutamine (21, 51). In support of this are the following 
facts: transamination of BCAA with alpha-ketoglutarate occurs at a 
rate 100 times that with pyruvate, making the direct transamination 
with pyruvate to form alanine unlikely (21); the intramusccular con¬ 
centration of alpha-ketoglutarate is close to the of alpha-keto- 
glutarate transaminase (21); BCAA increases the in vitro production 
of glutamate as well as alanine (21). Most recently, Ben Galjm et 
al (52) studied BCAA nitrogen transfer to alanine in vivo in dogs by 
15 measuring the transfer of N from leucine to alanine in the whole 
animal as well as across the isolated hindlimb. They found that 
nearly half of leucine nitrogen was transferred to alanine, and it 
represented 18% of the nitrogen in alanine. If the nitrogen con¬ 
tribution of the other BCAA, valine and isoleucine, is comparable, 
then greater than half of alanine nitrogen could be derived from 
BCAA. Interestingly, they found that each hindlimb could only 
15 account for 6% of the total body N-alanine production. The au¬ 
thors postulate that nitrogen may be transferred from the peripher¬ 
ally degraded BCAA to a metabolic intermediate which then transfers 
it to alanine in other body tissues. The possibility that gluta¬ 
mine might serve as this intermediate is intriguing in view of its 
prominent conversion to alanine in the intestine. 
A number of clinical observations have underscored the physio¬ 
logic importance of the glucose-alanine cycle and have supported the 
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primacy of BCAA and glucose-derived pyruvate in the peripheral syn¬ 
thesis of alanine in vivo. Children with maple syrup urine disease 
(MSUD) have a branched chain alpha-ketoacid dicarboxylase deficiency 
which blocks BCAA catabolism (54, 55). These patients have plasma 
alanine levels 3-10 fold lower than normal and suffer from hypogly¬ 
cemic episodes (21, 43), despite normal concentrations of gluco- 
regulatory hormones (56). Recent studies by Raymond et al (56) have 
revealed that in the basal state, patients with MSUD have elevated 
plasma leucine and decreased alanine levels. After a 24 hour fast, 
their BCAA concentrations rise, in marked contrast to controls. In 
addition, basal alanine flux rates, measured using stable isotopes, 
were strikingly lower in MSUD patients than in controls. Finally, 
in one patient with a partial enzymatic deficiency, the plasma ala¬ 
nine and BCAA levels as well as the alanine flux rate were inter¬ 
mediate between those of controls and classic MSUD patients. These 
studies suggest that BCAA degradation is a critical and rate-limit¬ 
ing event for alanine synthesis in vivo. Children with ketotic hy¬ 
poglycemia are also prone to hypoglycemic episodes after brief 
fasting (57, 58). These episodes are associated with lowered ala¬ 
nine and raised BCAA levels (57), That hepatic gluconeogenesis is 
uniimpaired in these patients is strongly suggested by the fact that 
alanine infusion results in prompt hepatic glucose production and 
resolution of symptoms (54). The above observations suggest that 
this syndrome, too, may be due to impaired BCAA degradation. 
The primacy of pyruvate as a precursor for peripheral alanine 
synthesis is suggested by observations in exercising man, in whom 





direct proportion to elevations in arterial pyruvate concentrations 
(7, 23, 59). In McArdle's syndrome (23), a disorder characterized 
by myophosphorylase deficiency and impaired muscle glycogen utiliza¬ 
tion, the arterial pyruvate level falls after exercise, and this is 
accompanied by a decline in alanine concentration. Finally, in 
children with inborn errors of metabolism resulting in hyperpyruvic- 
acidemia, arterial alanine levels are elevated (60). 
V. The Effect of Insulin and Glucagon on Amino Acid Metabolism 
Apart from their regulation of gluconeogenesis (discussed 
above), insulin and glucagon play an important role in amino 
acid metabolism. Weichmann (61) first reported in 1924 that, after 
insulin administration, diabetics exhibit decreased levels of blood 
amino acid nitrogen. Numerous studies (62-65) in animals and humans 
have since confirmed the ability of both endogenous and exogenous 
insulin to lower amino acid concentration. Zinneman et al (62) and 
Felig et al (63) have reported significantly depressed arterial lev¬ 
els of valine, leucine, isoleucine, tyrosine, phenylalanine, methio¬ 
nine, following endogenous insulin secretion in man. That insulin 
lowered amino acid levels by a peripheral effect was first suggested 
by studies demonstrating a progressive rise in amino acid concentra¬ 
tions in cats after eviscaration (64) - a rise prevented by insulin 
administration. Lotspeich (65) observed that dogs, after insulin 
administration, exhibited lowered blood amino acid levels in pro¬ 
portion to their relative concentrations in muscle. Subsequently, 
Pozefsky et al (3) infused physiologic quantities of insulin into 
the brachial artery of human subjects and measured amino acid bal¬ 
ances across the forearm. They noted a 75% decline in total amino 
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acid nitrogen output, with a consistent decline for only leucine, 
isoleucine, threonine, phenylalanine, 'tyrosine, glycine. The fact 
that the very same amino acids whose concentrations declined after 
systemic insulinization (62, 63) exhibited diminished forearm re¬ 
lease after local insulinization suggested that insulin's systemic 
effect is the result of its inhibitory action on muscle amino acid 
release. The above studies have also revealed that alanine arterial 
concentration and net muscle release are not significantly affected 
by insulin. This probably reflects insulin's ability to stimulate 
alanine synthesis via the glucose-alanine cycle (21, 23) and not 
alanine's insensitivity to the hormone. 
In assessing insulin's effect on net amino acid muscle release, 
one must consider its effect on amino acid transport, protein syn¬ 
thesis, and protein degradation. Several in vitro studies (61, 66) 
have demonstrated that insulin, in fact, stimulates all three pro¬ 
cesses. Fulks et al (66) have documented in rat diaphragms that 
insulin's effects on protein synthesis and degradation are quanti¬ 
tatively comparable with regard to their contribution to the regula¬ 
tion of peripheral amino acid release. Jefferson et al (61) con¬ 
firmed these findings in perfused rat hemicorpus and found that in¬ 
sulin deficiency reduced the rate of protein synthesis by blocking 
peptide chain initiation. Pain and Garlick (67) studied protein 
synthesis in skeletal muscle of normal, streptozotocin diabetic and 
insulin-treated rats in vivo, by constant infusion of labelled amino 
acids. They found that the diabetic rats exhibited a 70% reduction 
in their rate of protein synthesis which was not seen in insulin- 
treated rats. 
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Although its role in the regulation of hepatic gluconeogenesis 
has been fairly extensively studied (2, 5, 23, 26, 31, 39-43), glu¬ 
cagon's physiologic effects on extrasplanchnic amino acid metabolism 
remain somewhat obscure. Bondy and Cerdillo (68) first noted in 
1956 that glucagon infusion resulted in a steady decline in whole 
blood alpha amino nitrogen concentration. The hypoaminoacidemic 
effect of glucagon has since been confirmed by numerous studies (73- 
75) and has been demonstrated to be most striking for alanine. Sev¬ 
eral in vitro and in vivo studies have suggested that glucagon has 
a catabolic extrahepatic effect on amino acid metabolism (70-74). 
Peterson et al (70) first reported that glucagon increases amino 
nitrogen release by rat adductor muscle in vitro. Hait et al (71) 
have shown that glucagon inhibits incorporation of amino acids into 
myocardial protein. Buse et al (72) demonstrated that glucagon 
stimulates BCAA oxidation in isolated rat myocardium. The physio¬ 
logic significance of the aforementioned studies (68-72) is uncer¬ 
tain inasmuch as they all employed pharmacologic doses of glucagon. 
In addition, since glucagon causes insulin secretion (2, 73) which, 
in turn, influences amino acid metabolism, the independent effect of 
glucagon cannot be deduced from the above studies. 
To examine the independent effect of glucagon on extrasplanch- 
nic amino acid metabolism, Lacy et al (73) infused glucagon into in¬ 
sulin-dependent diabetics and found that alanine''s'arterial 
concentration fell dramatically without a significant change in 
its splanchnic uptake, suggesting a peripheral effect of glucagon. 
They infused supraphysiologic doses of glucagon, however. Marliss 
et al (74) continuously infused insulin-deficient fasting human sub- 




jects with physiologic doses of glucagon. They observed a 15% re¬ 
duction in total amino acid concentration and, in the absence of a 
rise in urea excretion, postulated an extrasplanchnic effect of glu¬ 
cagon on amino acid metabolism. Pozefsky et al (75) subsequently 
directly studied glucagon's effect on peripheral amino acid metabo¬ 
lism by infusing physiologic doses of glucagon into the brachial ar¬ 
tery of postabsorptive and insulin-deficient starved human subjects. 
They found that, in both postabsorptive and starved states, physio¬ 
logic increments of glucagon have no effect on amino acid balance 
across forearm tissue in man. 
VI. Intestinal Absorption of Amino Acids 
The major products of intraluminal protein digestion are 
amino acids and small peptides, each of which is absorbed across the 
intestinal mucosa via an independent transport mechanism. Studies 
in animals and man (77-80) have demonstrated the presence of and 
characterized four distinct amino acid transport systems - for neu¬ 
tral amino acids (which include the BCAA, alanine, glycine, gluta¬ 
mine, methionine, phenylalanine, typtophan, tyrosine), dibasic 
amino acids, dicarboxylic (acidic) amino acids, and imino acids plus 
glycine. The neutral amino acid transport system, the most function¬ 
ally important and extensively studied mechanism, is an active pro¬ 
cess, transporting amino acids uphill against a cell to lumen concen¬ 
tration gradient; is sodium dependent; and involves the formation of 
a ternary complex comprising sodium, amino acid, and a membrane 
carrier (77-79). It has also been demonstrated that there is compe¬ 
tition for transport sites amongst amino acids sharing a common 
transport mechanism (81). Thus, the rates at which individual amino 
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acids are absorbed are significantly altered by the presence of oth¬ 
er amino acids. Studies in animals (86, 83) and man (81) have 
demonstrated that the BCAA and methionine have the highest affinity 
for the neutral transport system and are therefore absorbed most 
rapidly. In addition, these amino acids inhibit the absorption of 
amino acids with lower transport affinities such as threonine and 
typtophan. 
Although early studies suggested that there is significant in¬ 
traluminal mixing of exogenous and endogenous protein after a meal, 
Adibi et al (84) conclusively demonstrated that in man, after a pro¬ 
tein meal, there is a strong correlation among the increase in 
intraluminal amino acid concentrations, the magnitude of rise in 
plasma amino acid levels and the amino acid composition of the in¬ 
gested protein. The authors concluded that exogenous protein con¬ 
stitutes the primary component of the intraluminal amino acid rise 
after a protein meal. They found, furthermore, from the amino acid 
analysis of ileal and jejunal aspirates after protein ingestion, that 
the process of protein digestion extends for greater than four hours 
and occurs in the ileal as well as the jejunal segments of the small 
intestine. Several studies in animals (9, 19) and man (20, 76) have 
since confirmed that the combined processes of digestion and absorp¬ 
tion take at least 3-4 hours. 
VII. Influence of the Route of Amino Acid Administration 
on its Metabolism 
It is known that oral glucose administration results in a 
greater insulin secretory response than does equivalent intravenous 
administration (85, 86). It has furthermore been demonstrated that 




oral glucose stimulates the secretion of the gastrointestinal hor¬ 
mone, GIF (gastric inhibitory polypeptide), which in turn enhances 
the release of insulin from pancreatic beta cells (87), It was 
thought that the hyperinsulinemia associated with oral glucose in¬ 
gestion accounted for the superiority of oral glucose tolerance. 
Recently, however, Lickley et al (88) and DeFronzo et al (103) in the 
dog and human, respectively, have demonstrated that the augmented 
hepatic glucose extraction observed following glucose ingestion as 
compared to intravenous administration is not the result of concom¬ 
itant hyperinsulinemia or hyperglycemia but reflects the stimulation 
by oral glucose of a gastrointestinal factor, as yet unidentified, 
which enhances insulin's effect on hepatic glucose metabolism. 
The role of the splanchnic bed in the metabolism of intra¬ 
venously administered amino acids has not been examined. Further¬ 
more, despite the widespread use of amino acid solutions in paren¬ 
teral alimentation, there is little data on the influence of the 
route of amino acid administration on its metabolism. Bypassing the 
gut and liver, intravenously administered amino acids might escape 
significant hepatic extraction and more effectively replete muscle 
nitrogen then ingested amino acids (20, 76). In addition, if after 
ingestion of amino acids, as after glucose, a gut factor were to 
be secreted which modulated insulin's effect on hepatic amino acid 
metabolism, then its absence following intravenous amino acid ad¬ 
ministration might favor the espace of amino acids to the periph¬ 
ery to replete muscle nitrogen,, In this regard, Bloomgarden et al 
(19), in their recent studies on amino acid metabolism by the liver 
and intestine after protein and glucose ingestion, found a strong 
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correlation between gut output and hepatic uptake of amino acids„ 
They postulated the existence of a mechanism, the mediators of which 
are unknown, which tightly links amino acid release by intestinal 
tissues with uptake by hepatic tissues. Their findings suggest that 
the route of amino acid administration is an important determinant 
of its hepatic extraction. Waterhouse et al (89) examined the 
change in amino acid arterial concentration and arteriovenous dif¬ 
ference across the forearm of human subjects undergoing parenteral 
al imentation with amino acid solutions. They found that, despite 
up to five-fold increases in amino acid arterial levels, there was 
no significant positive change in the arteriovenous difference 
across the forearm for any of the administered amino acids. They 
suggested that the initial processing of amino acids during reple¬ 
tion of muscle nitrogen occurs in extraskeletal tissues. One of 
the objectives of the current study was to elucidate the roles of 
the hepatic and intestinal tissues in the metabolism of amino acids 
administered via the intravenous route as well as to examine the 
influence of the route of administration on amino acid metabolism. 
VIII. Amino Acid Transport 
Since Winter et al (90) reported that the migration of amino 
acids across the human erythrocyte membrane occurs at a very slow 
rate in vitro, it has been generally accepted that plasma rather 
than erythrocytes is the primary vehicle for interorgan amino acid 
transport. The validity of this assumption was first questioned by 
Elwyn et al (25, 9) whose in vivo dog studies revealed that red 
blood cells do indeed play a significant role in amino acid trans¬ 
port. They demonstrated that the rates of change of concentration 
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and specific activity of glycine and serine in erythrocytes during 
transversal of the capillary and sinusoidal beds of gut and liver 
were twenty-fold faster than rates observed between plasma and 
erythrocytes in vitro. They concluded that there is direct exchange 
of amino acids between tissue cells and erythrocytes as the latter 
pass through gastrointestinal organs and that this exchange is in¬ 
dependent of and frequently progresses in the opposite direction of 
that between plasma and tissues cells. 
The importance of red blood cells in interorgan amino acid 
transport in man was first suggested by Aoki et al (91) who found 
that the stimulatory effect of insulin on muscle glutamate uptake 
was only manifested upon analysis of whole blood but not plasma 
arterio-deep venous differences. They thus implicated circulating 
erythrocytes as an important vehicle for glutamate transport and 
underscored the need for whole blood analysis in investigations of 
interorgan amino acid movements. Felig et al (8) subsequently de¬ 
termined peripheral, splanchnic and portal exchange of seventeen 
individual amino acids in healthy postabsorptive human subjects, 
measuring both plasma and whole blood arteriovenous differences. 
They found that blood cellular elements carried significant quanti¬ 
ties of all amino acids in a direction which generally paralleled 
the net fluxes occurring in plasma. Glutamine was unique in that 
its movement via plasma and erythrocytes proceeded in opposite di¬ 
rections upon passage through the intestine. Alanine predominated 
in amino acid transport via erythrocytes as it does via plasma, with 
30% of its leg and intestinal output and 22% of its splanchnic up¬ 
take occurring by the former mode of transport. Finally, Aoki et al 
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(22) measured amino acid differences after protein ingestion across 
the forearm of a single nitrogen-depleted subject fasted for six 
weeks. They found that one-third to one-half of peripheral BCAA 
uptake occurred via erythrocytes. As a result of the above data 
documenting the pivotal role of red blood cells in interorgan amino 
acid transport, all amino acid measurements in the current study 
were performed on whole blood samples. 
METHODS 
Subjects and Materials. Unanesthesized mongrel dogs of either 
sex weighing between 16.4 and 29.1 kgs (mean 22.7±1.6) were studied. 
3 
(3- H) glucose from New England Nuclear (Boston, Mass.) served as 
the labelled tracer for glucose production. Glucagon and insulin 
were purchased from Eli Lilly Co. (Indianapolis, Ind.). FreAmine 
II 8.5% (composition [mg/dl]): isoleucine, 590; leucine, 770; ly¬ 
sine, 370; methionine, 450; phenylalanine, 480; threonine, 340; 
tryptophan, 130; valine, 560; alanine, 600; arginine, 310; histi¬ 
dine, 240; proline, 950; serine, 500; glycine, 1700; cysteine HCl, 
<20 was obtained from Abbott Laboratories (North Chicago, Illinois). 
Silastic catheters were purchased from Dow Corning Co. (Midland, 
Mich.). Hepatic blood flow was determined using Cardiogreen dye, 
Hynson, Westcott, and Dunning Co. (Baltimore, Md.). Infusions were 
carried out on Harvard Apparatus Infusion Pumps. Ion-exchange 
chromatography was performed on a Beckman Model 120C amino acid 
analyzer (Beckman Instrument Co., Palo Alto, Cal.). Plasma glucose 
was measured on a glucose analyzer (Yellow Springs Instrument Co., 
Yellow Springs, Oh.). 




anaesthesia via a midline laparotomy. Silastic catheters (.125" 
O.D., .062" I.D.) were inserted into the left common hepatic vein, 
portal vein, mesenteric vein, and a branch of the iliac artery. The 
left common hepatic vein was cannulated in antegrade fashion as 
described by Shoemaker et al (92). The tip of the catheter was 
modified by the deposition of two raised silastic rings between 
which a purse string suture was placed, securing the catheter in 
its place and preventing its advancement into the inferior vena 
cava. The portal catheter was guided cephalad through a tributary 
of the portal vein until its sampling tip rested at the porta he- 
paticus, allowing for the sampling of mixed portal blood including 
pancreatic drainage. Catheters were flushed early with saline to 
prevent clotting. At the end of the procedure, catheters were 
filled with heparin (300 U/ml) and brought out through the abdominal 
fascia and then tunneled subcutaneously to the midscapular region, 
occluded, and buried in a subcutaneous pouch. An incision, through 
which the catheters were drawn to the outside at the time of experi¬ 
mentation, was sutured to prevent the dog from gaining access to the 
catheters and to lower the risk of infection. One to three weeks 
were allowed for recovery from surgery, during which time dogs were 
maintained on a diet comprising 450 g of canned meal daily and un¬ 
limited dry chow. 
Experimental Design. After an overnight 18 hour fast, dogs 
were restrained in harnesses. Skin in the midscapular region was 
infiltrated with lidocaine, catheter ends were exteriorized and 
their patency maintained by a continuous saline drip, A 16-gauge 
intravenous catheter was placed in the saphenous vein for the infu- 
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sion of indocyanine green dye, amino acids, and 3- H-glucose, Primed (3 
mg) continuous (300 ug/min) infusions of indocyanine green dye were begun 
90 min prior to and continued for the duration of the studies. Body glu¬ 
cose turnover was measured in 4 dogs in both the intravenous and oral 
studies. Dogs received primed (15 yCi) continuous (0.,15 yCi/min) infu- 
3 
sions of 3- H-glucose 90 min prior to and for the length of the studies. 
In the oral studies, nine dogs consumed within 5 minutes 700 
mg/kg body weight of the crystalline amino acid mixture Freamine 
8.5%, diluted 1:1 with isotonic saline. Dogs in the intra¬ 
venous studies received a 10 minute priming dose followed by a con- 
tinuous infusion of Freamine II^ ' 8.5%, Five dogs received a total 
dose of 720 mg/kg (low-dose infusion) and five received a total of 
1440 mg/kg (high-dose infusion) of amino acids. The rates of infu¬ 
sion of 14 amino acids during the last 170 minutes of the low-dose 
10- 
studies are listed in Table 10. In all I.V. studies, the rate of in¬ 
fusion of the priming dose was twice that of the continuous infusion. 
The rate of infusion in the low-dose studies was calculated to a- 
chieve whole blood amino acid levels similar to those obtained in 
the oral studies in order to assess the influence of the route of 
administration on amino acid disposal independent of differences in 
concentration. In two of the dogs receiving low-dose infusions the 
route of administration was via a mesenteric rather than a saphenous 
vein. This was undertaken to further elucidate the effect of the 
route of administration on hepatic amino acid metabolism. 
In all studies, whole blood samples for determination of amino 
acid concentrations were collected simultaneously from the hepatic 
vein, portal vein, and a branch of the iliac artery at timed inter- 
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vals during a 30 minute basal period and for 3 hours after Fre- 
f R) amine^ ' administration and set on ice. Plasma glucose concentra- 
3 
tion, 3- H-glucose specific activity, and arterial blood hematocrit 
were determined at 15 minute intervals for 30 minutes prior to 
amino acid administration and for the duration of the studies. Por¬ 
tal plasma glucagon and portal and arterial insulin concentrations 
were determined twice in the postabsorptive state and at 30 minute 
intervals throughout the studies. 
Calculations. Hepatic plasma flow was determined according to 
the Pick principle by a continuous infusion of indocyanine green dye 
according to the methods described by Bradley et al (93) and Leevy 
et al (94). Hepatic blood flow was calculated by dividing the plas¬ 
ma flow by (1 - hematocrit). Indocyanine green dye was determined 
spectrophotometrically at 805 nm in serum samples. Uptake and pro¬ 
duction of metabolites in the splanchnic area were calculated by 
the arteriovenous (A-V) difference technique. This was accomplished 
by determining arterial, portal and hepatic venous metabolite con¬ 
centrations and assuming that 80% of the hepatic blood flow is de¬ 
rived from the portal vein while 20% comes from the hepatic artery 
(95), The actual formulae used in the determination of the hepatic, 
splanchnic and extrahepatic splanchnic organ balances were as fol¬ 
lows : 
Splanchnic Substrate Balance = 
([Substrate]^ - [Substrate]j^y) x Hepatic Flow 
Extrahepatic Splanchnic Substrate Balance = 
([Substrate]^ - [Substratejpy) x 0.8 x Hepatic Flow 
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Hepatic Substrate Balance = 
jj[Substrate]py - [Substrate]|^y) x 0o8 + ([Substrate]^ - 
[Substrate]^^) x x Hepatic Blood Flow 
where subscripts A, HV, and PV designate artery, hepatic vein, and 
portal vein, respectively. 
From the above formulae, it is apparent that: 
Splanchnic Substrate Balance = 
Hepatic Substrate Balance + Extrahepatic Splanchnic Substrate 
Balance 
The hepatic extraction ratio was calculated using the following 
equation: 
Hepatic Substrate Extraction Ratio = 
(0.8 X [Substrate]py + 0.2 x [Substrate]^)- [Substratelpj^ 
(0.8 X [Substratejpy 0.2 x [Substratej^^) 
While amino acid balances were determined using whole blood 
concentrations and hepatic blood flow, glucose balances were calcu¬ 
lated employing plasma levels and hepatic plasma flow inasmuch as 
erythrocytes do not actively participate in interorgan glucose 
transport in the dog (95). 
In addition to the A-V difference technique, the rates of en¬ 
dogenous glucose production and utilization following amino acid 
administration were determined employing the primed tracer infusion 
method. Calculation of the rates of appearance (Ra) and disappear¬ 
ance (Rd) of glucose was performed according to the two-compartment 
analysis of glucose kinetics proposed by Radziuk et al (96). This 
model corrects for the fact that rapid changes in the concentration 
and specific activity of glucose do not occur uniformly 
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throughout the glucose pool. It assumes, that the first compartment 
contains the vascular space, and that it is this compartment in which 
concentrations of labelled and unlabelled glucose are determined and 
glucose and tracer appear. In this manner, reliable measurements of 
non-steady state turnover rates have been attained. The metabolic 
clearance rate of glucose was calculated from the ratio of Rd to 
plasma glucose. 
3 
To determine 3- H -glucose, plasma was deproteinized using 
c, 
zinc sulfate, and barium hydroxide as the alkali according to the 
Somogyi-Nelson technique (97, 98). The protein-free supernatant 
was placed in a vacuum oven at 70°C overnight in order to evaporate 
radioactive water from the glucose samples. Samples were then re¬ 
constituted with water and their radioactivity determined using li¬ 
quid scintillation procedures. 
All amino acid determinations were performed on whole blood. 
Blood for amino acid analysis was deproteinized with equal volumes 
of 10% sulfosalicylic acid (99) and spun at 10,000 r.p.m, for 20 
minutes. To remove glutathione, which emerges as a broad peak under¬ 
lying many amino acids and thus interferswiththe chromatographic de¬ 
termination of amino acids in whole blood, the whole blood filtrates 
were treated with sodium sulfite prior to chromatographic analysis. 
The filtrates (2.0 ml) were first neutralized to pH 7.0 with 4N NaOH, 
after which (0.1 ml) 0.5M sodium sulfite was added and the solution 
placed in a shaker at room temperature for two hours. Filtrates 
were then reacidified with HCl to pH 2.2 (99) and determinations 
made using automated ion-exchange chromatographic techniques (99) on 
a Beckman Model 120C amino acid analyzer. 
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Plasma glucose was analyzed by the glucose oxidase reaction 
(100) using a glucose analyzer. Plasma glucagon was analyzed by 
radioimmunoassay using Unger antibody 30K (102). Insulin was de¬ 
termined with talc to separate bound from free insulin. Hematocrit 
was measured for each time interval using a microcapillary hemato¬ 
crit centrifuge. 
Data in the text, tables, and figures are given as the mean 
± SEM, Standard statistical methods have been employed (102), with 
paired t-test when applicable, 
RESULTS 
I. Oral Studies 
A. Postabsorptive State 
a. Whole Blood Amino Acid Concentration and Balances. The 
whole blood arterial, portal, and hepatic venous concentrations of ten 
amino acids in nine dogs in the postabsorptive state are shown in 
Table 1. Postabsorptive hepatic, extrahepatic splanchnic, and splanch¬ 
nic balances for these amino acids (Table II) are in close agreement 
with earlier observations (2, 6-9, 19). In the basal state, the extra- 
hepatic splanchnic tissues produced significant amounts of alanine, 
but net extrahepatic splanchnic balances were not significant for any 
of the other glucogenic or branched chain amino acids. The liver re¬ 
moved alanine and other glucogenic amino acids but not the BCAA. The 
basal hepatic extraction ratios for alanine, glycine, and serine were 
31±5%, 22±4%, and 29±4%, respectively, while those for the BCAA were 
not significantly different from zero (Table III). There was a net 
splanchnic uptake of alanine, reflecting the hepatic metabolism of 
alanine derived from both extrahepatic splanchnic and peripheral tissues. 
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b. Plasma Glucose Concentrations and Balances. The mean basal 
arterial, portal, and hepatic venous concentratons were 97±3, 95±4, and 
105±3 mg/dl, respectively, reflecting hepatic production and intestinal 
extraction of glucose in the postabsorptive state. The rates of extra- 
hepatic splanchnic removal, hepatic production, and net splanchnic pro¬ 
duction of glucose were 0.8±0.1, 2.9±0.3, and 2.1±0.3 mg/min-kg, re¬ 
spectively. 
B. Postcibal (i.e., Post-Ingestion) State 
a. Whole Blood Amino Acid Concentrations and Balances. The 
whole blood arterial, portal and hepatic venous concentrations and the 
hepatic, extrahepatic splanchnic, and splanchnic balances for ten amino 
acids during the 3 hours post-ingestion are shown in Tables I and II, 
respectively. The portal concentrations of all amino acids present in 
the Freamine IP mixture rose by 15 minutes post-ingestion, re¬ 
flecting prompt intestinal uptake. Peak portal concentrations (Table 
I) and extrahepatic splanchnic release (Table II) of ingested amino 
acids generally occurred at 60-90 minutes post-feeding, although in¬ 
testinal absorption, as reflected by increased portal concentrations 
and extrahepatic splanchnic release, was still ongoing at 180 minutes. 
The mean hepatic, extrahepatic splanchnic, and splanchnic balances for 
alanine, glycine, proline, serine, and tyrosine are shown in Figure I. 
Those for leucine, isoleucine, and valine are shown in Figure II. For 
all amino acids, intestinal absorption was accompanied by an increase 
in hepatic uptake. For glycine, proline, and serine, mean hepatic up¬ 
take generally paralleled mean extrahepatic splanchnic release, re¬ 
sulting in a net splanchnic balance similar to that in the postabsorp- 





nic output, resulting in an increased net splanchnic uptake above that 
in the postabsorptive state. Intestinal output of BCAA exceeded their 
extraction by the liver, resulting in a net splanchnic release of 
these amino acids. 
The amino acid doses as well as the cumulative hepatic, extra- 
hepatic, and splanchnic balances during the 3 hr postcibal period are 
shown in Table IV. On comparing the extrahepatic splanchnic balances 
and the oral doses of each amino acid, it is apparent that all of the 
glucogenic amino acids and 80% of the BCAA were absorbed during the 3 
hr study. The cumulative intestinal release of alanine exceeded the 
administered dose by 47%, reflecting continued gut production of this 
amino acid in the postcibal state. In addition, during the 3 hr post¬ 
cibal period, the liver removed 1736±166 ymoles/kg of alanine, a 
quantity three-fold greater than the oral dose of alanine and two-fold 
greater than its extrahepatic splanchnic output which comprises both 
the ingested load and the postcibal intestinal production of alanine. 
The rate of splanchnic alanine uptake was 63% greater than that in the 
basal state. In association with alanine's rising arterial level in 
the postcibal state, this suggests stimulation of peripheral alanine 
production in the fed state. 
The liver took up 44% of the absorbed and 35% of the administered 
load of BCAA. However, since the extrahepatic splanchnic release ex¬ 
ceeded their removal by the liver, there was a net splanchnic release 
of these amino acids to the periphery. Over the 3 hrs following pro¬ 
tein ingestion, a total of 538±183 ymoles/kg of BCAA were released from 
the splanchnic bed. During this same time period, there was a net 
splanchnic uptake of 1480±450 ymoles/kg of glucogenic amino acids, of 
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which alanine constituted 891±142 ymoles/kg (Table IV). Thus, despite the 
splanchnic escape of BCAA, the net flux of amino acids from the peripheral 
to the splanchnic tissues persisted in the fed state. Finally, the hepa¬ 
tic extraction ratios of all amino acids rose after protein ingestion al¬ 
though only the increases in the extraction of glycine, proline, leucine, 
and valine were statistically significant (i.e., p<0.05) (Table III). 
b. Plasma Glucose Concentrations and Balances,. The mean plasma 
arterial, portal, and hepatic venous concentrations of glucose in nine 
dogs in the postabsorptive state and for the 3 hrs following amino acid 
ingestion are plotted in Figure 3. Glucose concentrations in all three 
vessels fell slightly over the duration of the study and by 180 min were 
7 mg/dl below basal. The hepatic, extrahepatic splanchnic, and splanchnic 
glucose balances in the basal state and for 3 hours post-ingestion are 
shown in Figure 4. Intestinal uptake of glucose rose shortly after in¬ 
gestion, peaked at 75-120 mins, and returned to basal by 165 mins. The 
rate of hepatic glucose release rose from 2.87±0.3 mg/min*kg in the post- 
absorptive state to 4,15±0.2 mg/min*kg at 75-90 mins and returned to base¬ 
line by 150 mins. Net splanchnic glucose release rose from 2.10±0.3 
mg/min*kg to a peak of 2,99±0,1 by 75-90 min and returned to basal by 150 
min. Inasmuch as the extrahepatic splanchnic tissues took up glucose 
throughout the postcibal period, the rise in the splanchnic release of 
glucose was solely due to its increased hepatic production. 
The rates of appearance (Ra), disappearance (Rd) and metabolic clear¬ 
ance of glucose in four dogs in the basal and postcibal states are shown 
in Figure 5. All three parameters rose shortly after protein ingestion 
and peaked at 45-60 min. The rise in Rd exceeded that of Ra, accounting 
for the slight decline in arterial glucose concentration. By 105 min 
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after ingestion, all three parameters had returned to their basal values. 
Mean portal glucagon and insulin levels in the basal and post-cibal 
states are shown in Figure 6. The mean portal glucagon concentration rose 
immediately following ingestion, peaked at times basal by 30 min, and 
remained significantly elevated (p<0.05) for the entire 3 hr post-cibal 
period. Mean portal and arterial insulin levels rose significantly (p< 
0.050) by 30 min post-ingestion but returned to baseline by 90 min. 
Hepatic plasma flow was 37±3 ml/min*kg in the postabsorptive state 
and did not significantly change during the 3 hr post-cibal period (Figure 
3). 
II. Intravenous Studies 
A. Postabsorptive State 
a. Whole Blood Amino Acid Concentrations and Balances. The mean 
whole blood arterial, portal, and hepatic venous concentrations in the 
postabsorptive state in 5 dogs receiving low dose infusions and 5 dogs re¬ 
ceiving high dose infusions are shown in Tables 5 and 6, respectively. 
Hepatic, extrahepatic splanchnic, and splanchnic balances in the basal 
state and during high-dose I.V. amino acid infusion are shown in Figures 
7 and 8. Basal intestinal and hepatic metabolism of BCAA and glucogenic 
amino acids was similar to that observed in the oral studies. For the 
BCAA, there was no significant uptake or release by either the intestine 
or the liver. Alanine was released by the gut, removed by the liver, and 
taken up by the splanchnic bed as a whole in significant quantities. The 
postabsorptive hepatic extraction ratios for alanine, glycine, and serine 
were 35±6, 27±4, and 24±6, respectively, while those for the BCAA were not 
significantly from zero (Table 7). 
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received high-dose infusions, mean plasma arterial, portal and hepatic 
venous concentrations in the postabsorptive state were 99+3, 97±3, and 
107±3, respectively (Figure 9). In the 5 dogs receiving low dose in¬ 
fusions, arterial, portal and hepatic venous concentrations were 98±5, 
96±5, and 105±5, respectively. The rates of extrahepatic splanchnic 
uptake, hepatic production, and net splanchnic production of glucose in 
the low dose group were 0.6±0»2, 2,9±0.6, and 2,3±0.5, respectively (Fig¬ 
ure 10), In the high-dose group, the corresponding values were 0.6±0.1, 
2.6±0.3, and 2.0±0.3 (Figure 9). In the 4 dogs whose glucose turnover 
was measured isotopically, postabsorptive rates of glucose appearance 
(Ra), disappearance (Rd), and metabolic clearance (MCR) were each 3.8±0.2 
mg/min-kg (Figure 11). 
B, Intravenous Amino Acid Infusion 
a. Whole Blood AminoAcid Concentrations and Balances. 
1, High-Dose Studies, The mean whole blood arterial, hepatic 
and portal venous concentrations for ten amino acids during the 3 hr high- 
dose intravenous amino acid infusion are shown in Table 6. All amino 
acid concentrations peaked at 15 min, shortly after the infusion of the 
priming dose, delivered at a rate double that administered for the dura¬ 
tion of the study. Glycine, the most abundant component of the Freamine 
(R) II' ' solution, rose most prominently. Relatively steady blood levels in 
all 3 vessels were maintained during the last 2 hr of the study by the 
continuous infusion of the amino acid mixture. Arterial levels of the 
BCAA generally exceeded portal levels (p<0,05, for each) during the 3 
hr infusion. As in the postabsorptive state, portal concentrations of 
alanine significantly (p<0,001) exceeded arterial levels at all times 
during the 3 hr infusion. In contrast, arterial and portal concentra- 





tions of threonine, serine, proline, glycine, and phenylalanine were not 
significantly different from those in the postabsorptive state. 
Analysis of hepatic, extrahepatic splanchnic, and splanchnic balances 
for the BCAA (Figure 6) reveals that during the 3 hr high dose infusion, 
hepatic, intestinal and net splanchnic uptake rose dramatically. All 
three parameters for valine, leucine, and isoleucine generally peaked by 
15 min and remained elevated for the duration of the study. The contri¬ 
bution of the liver and the extrahepatic splanchnic tissues to the hand¬ 
ling of the infused amino acid load,integrated over the 3 hr infusion 
period, is shown in Table 8. The hepatic and intestinal tissues both 
disposed of comparable quantities of BCAA and together metabolized 973±253 
ijmoles/kg or 37% of the administered BCAA load. Amino acid hepatic ex¬ 
traction ratios during the last 2 hr of the high-dose infusion, during 
which time blood amino acid levels were relatively steady, are shown in 
Table 7. Extraction ratios for leucine, isoleucine, and BCAA as a group 
rose significantly (p<0.05) from basal values. 
During the high-dose infusion, intestinal handling of alanine and 
other glucogenic amino acids was not significantly altered from basal 
despite greatly elevated arterial levels of these amino acids. Ala¬ 
nine and glycine continued to be released by the extrahepatic splanchnic 
tissues at rates not significantly different from those in the postabsorp¬ 
tive state. By contrast, hepatic uptake and, in turn, net splanchnic 
removal of these amino acids were dramatically increased during the high- 
dose infusion (p<0.001). Rates of hepatic and net splanchnic uptake of 
alanine and the other glucogenic amino acids generally peaked by 30 min 
and remained significantly elevated by 180 min. The cumulative splanch¬ 
nic uptakes, i.e., over the entire 3 hr infusion, of alanine, glycine. 
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and serine equalled or exceeded the total administered doses of these 
amino acids (Table 8). Despite this, arterial concentrations of these 
amino acids were continually elevated, reflecting continued net periph¬ 
eral production of these amino acids during the infusion. For phenylala¬ 
nine and proline, net splanchnic removal accounted for 75% and 53%, re¬ 
spectively, of the total administered dose of these amino acids. Of the 
58 pmoles/kg-min of amino acids infused over the 3 hr study, 51 ijnoles/ 
kg*min were metabolized by splanchnic tissues and 7 umoles/kg*min at 
peripheral sites (Table 8). The hepatic extraction ratios for alanine, 
glycine, serine, and proline all rose during the infusion, but only the 
increase in the hepatic extraction ratio for proline was statistically 
significant (i.e., p<0.05). 
2. Low-Dose Studies. The rates of continuous infusion of 14 
amino acids during the low-dose studies are shown in table 9. The mean 
whole blood arterial, portal, and hepatic venous concentrations for 8 
amino acids during the 3 hr low-dose intravenous infusions are shown in 
Table 5. Amino acid concentrations in all three vessels rose dramatically 
by 15 min after the beginning of the infusion and remained relatively 
steady for the entire 3 hr study. Blood amino acid levels during the in¬ 
fusion were similar to those observed in the oral studies following amino 
acid ingestion. 
Hepatic balances for 7 amino acids and the BCAA as a group are shown 
in Figure 11. Since 2 of the 5 dogs received low-dose infusions via a 
mesenteric vein, extrahepatic splanchnic and net splanchnic balances were 
not quantitated. Hepatic uptake of all amino acids rose shortly after 
the beginning of the infusion, generally peaked by 30 min, and remained 






























uptake for 5 dogs during the low-dose infusions is shown in Table 10. 
Hepatic removal of all glucogenic amino acids equalled or exceeded the 
administered dose of these amino acids. In association with continually 
elevated arterial levels of glucogenic amino acids, the results indicate 
that, as during high-dose amino acid infusion and following oral adminis¬ 
tration of amino acids, peripheral production of these amino acids con¬ 
tinues during the low-dose infusions. The liver extracted 39±5%, 28±4%, and 40±6% 
of the administered doses of leucine, isoleucine, and valine, respectively. 
The hepatic extraction ratios of all amino acids rose during the 
infusions, but none of the increases reached statistical significance. 
The mean hepatic extraction ratios for total BCAA in dogs receiving peripheral or 
mesenteric low-dose infusions were 1±\% and 9+1%, respectively. Corre¬ 
sponding values for glucogenic amino acids as a group were 32±2% and 31±2%. 
b. Plasma Glucose Concentrations and Balances. 
1. High-Dose Studies. Plasma glucose arterial, hepatic, and 
portal venous concentrations all declined during the infusion, and by 
180 min the arterial plasma glucose concentration was 12 mg/dl below ba¬ 
sal (Figure 9). Hepatic glucose production rose from 2.6±0.3 mg/min*kg 
to a peak of 4.9±0.6 mg/min*kg at 15-30 min and remained significantly 
elevated (i.e., p<0.05) up to 135 min (Figure 10). Extrahepatic splanch¬ 
nic as well as net splanchnic production of glucose also rose signifi¬ 
cantly (i.e., p<0.05) within minutes after the start of the infusion and 
remained significantly elevated to 75 and 135 min, respectively. 
In the four dogs whose glucose turnover was measured isotopically 
the rate of glucose disappearance (Rd) rose significantly (p<0.05) from 
3.8 mg/min*kg (basal) to 5.1±0.5 mg/min*kg, as did the metabolic clear¬ 
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60 min after the beginning of the infusion. The rate of glucose appear¬ 
ance (Ra) rose as well but not to a statistically significant degree 
(Figure il)j thereby accounting for the concomitant fall in plasma ar¬ 
terial glucose concentration. 
The mean portal plasma glucagon level rose from 162±40 pg/ml (basal) 
to 540±110 pg/ml by 30 min and remained at least three-fold elevated for 
the duration of the study (Table 11). Mean portal plasma insulin levels 
rose from 35±3 yU/ml (basal) to a peak of 121±19 yU/ml by 30 min, de¬ 
clined to 54±14 yU/rnl by 60 min^ and remained elevated for the duration 
of the study (Table 11). Arterial plasma insulin levels (not shown) 
similarly rose dramatically from 19±3 yU/ml (basal) to 63±5 yU/ml by 15 
min, then fell to 26±3 by 60 min and remained elevated for the entire 
180 min. 
2. Low-Dose Studies. Plasma glucose arterial hepatic and 
portal venous concentrations all declined during the low-dose infusion 
(Figure 9). By 180 min, the arterial plasma glucose concentration was 8 
mg/dl below basal. Hepatic, extrahepatic splanchnic, and splanchnic glu¬ 
cose balances were not significantly altered at any time during the low- 
dose infusion (Figure 10). 
The mean portal plasma glucagon level rose from 217±78 pg/ml (basal) 
to a peak of 410±155 by 90 min and remained elevated for the remainder 
of the 3 hour study period. The mean portal insulin level rose as well 
from 35±5 yU/ml (basal) to a peak of 60±18 yU/ml by 90 min but returned 
to the basal level by 150 min. 
Hepatic plasma flow did not significantly change during either the 







I. Oral Studies 
The current studies demonstrate, in keeping with earlier observa¬ 
tions (2, 7-9, 19), that in the postabsorptive state, the peripheral as 
well as the intestinal tissues produce significant amounts of alanine, 
all of which is effectively metabolized by the liver. There was no net 
exchange of other glucogenic amino acids across the extrahepatic splanch 
nic tissues in the basal state, but there was significant hepatic uptake 
of these amino acids, resulting in a small net splanchnic uptake. There 
was no significant net exchange of BCAA by either the liver or the extra 
hepatic splanchnic tissues. Overall, there was a net average flux of 
6.2 ymoles/min*kg of amino acid nitrogen from the peripheral to the 
splanchnic tissues. 
Following amino acid ingestion, portal concentrations and extra- 
hepatic splanchnic release of all amino acids rose rapidly, reflecting 
prompt intestinal absorption. Over the 3 hr study, the entire ingested 
loads of serine, glycine, phenylalanine, and proline, as well as 80% of 
the ingested BCAA were recovered in the portal blood (Table 4). While 
the ingested amino acid mixture contained 580 ymoles/kg of alanine, 853 
±118 ymoles/kg were recovered over the 3 hr study, reflecting continued 
alanine synthesis by intestinal tissues in the fed state. Bloomgarden 
et al (19) reported similar findings in their recent studies in dogs. 
Following feeding, there was a mean net splanchnic alanine uptake of 
4.95±0.8 ymoles/min-kg, a rate 63% greater than that observed in the 
postabsorptive state. In association with rising arterial concentra¬ 
tions of alanine, this indicates stimulation of peripheral alanine pro¬ 
duction in the post-cibal state and confirms the earlier observations of 









Bloomgarden et al (19). 
Although the origins of the carbon skeleton and amino group used in 
the peripheral synthesis of alanine were not investigated in the current 
studies, earlier observations (21, 23, 45, 49-52) strongly suggest that 
glucose-derived pyruvate and BCAA are the sources of the carbon skeleton 
and amino group, respectively (see Introduction). In this regard, net 
splanchnic release and peripheral uptake of glucose were significantly 
stimulated after amino acid ingestion (discussed below) to an extent 
which could provide sufficient carbon substrate for the peripheral ala¬ 
nine production observed. In addition, over the 3 hr study, 588±183 
ymoles/kg of BCAA escaped the splanchnic bed to the periphery as po¬ 
tential substrate for alanine synthesis. 
The likely source of the carbon skeleton used for intestinal ala¬ 
nine production in the post-cibal state is glucose-derived pyruvate as 
well. In this regard, intestinal uptake of glucose was significantly 
stimulated following amino acid ingestion (see below). Concerning the 
nitrogen source for intestinal alanine synthesis, the entire ingested 
load of all amino acids except the BCAA was quantitatively recovered in 
the portal blood, and it is thus unlikely that the former provided sig¬ 
nificant amounts of nitrogen substrate for alanine synthesis. Since the 
BCAA have the highest affinity for the neutral amino acid transport sys¬ 
tem (81-83), and are thus the most rapidly absorbed of all amino acids, 
it is unlikely that the lack of complete recovery in the portal blood of 
the ingested BCAA was due to impaired intestinal absorption. Rather, 
the 20% of BCAA not accounted for may have been used as substrate for 
intestinal alanine production. In addition, nitrogen may have been 
transferred from peripherally degraded BCAA to a metabolic intermediate 
















ferred it to alanine in intestinal tissue (see Introduction). In support 
of this hypothesis are the tracer studies of Ben Galim et al (52), demon¬ 
strating that while nearly half of labelled leucine nitrogen was trans¬ 
ferred to alanine, each hindlimb could account for only 6% of the total 
body labelled alanine production, suggesting that amino groups derived 
from the BCAA are transferred via an intermediate to alanine elsewhere in 
the body. 
A striking finding in the present studies was the hepatic uptake of 
35% of the ingested load of BCAA. Previous studies in dogs (9), rats (17), 
and sheep (18), have demonstrated very little hepatic removal of these 
amino acids. Bloomgarden et al, in their recent studies in dogs (19), 
noted a failure of the BCAA to be taken up by the liver. Thus, it has 
been generally assumed that the liver plays a passive role in the handling 
of these amino acids. The current studies conclusively demonstrate, how¬ 
ever, that approximately 45% of the absorbed BCAA is removed by the liver 
and that the hepatic tissues thus play an important role in the metabo¬ 
lism of these amino acids. Whether a similar function is served by the 
liver in man remains to be resolved. 
Analysis of the cumulative hepatic, extrahepatic splanchnic and 
splanchnic balances for all amino acids over the three postcibal hours 
(Table 4) reveals that the postabsorptive nitrogen flux from periphery 
to splanchnic tissues persisted after feeding. Net transfer of gluco¬ 
genic amino acids from the skeletal muscle tissues to the splanchnic bed 
exceeded splanchnic escape of BCAA to the periphery by 895 moles/kg-3 







have been reported in dogs (19) and man (20, 76). In addition, gluta¬ 
mine, not measured in the current studies, has been shown both in sheep 
(18) and man (20) to be prominently released by skeletal muscle tissue 
in the fed state and metabolized by the intestinal tissues. Thus, the 
net flux of amino acids from the periphery to the splanchnic bed is 
likely greater than that measured in the present studies. BCAA alone, 
then, do not replete muscle nitrogen stores after a protein meal. Since 
it is known that in animals and man muscle protein stores are indeed 
maintained, some nitrogen substrate not measured in this and other 
studies (19, 20, 76) may complement the BCAA in their role as nitrogen 
carriers to the periphery. 
Assessment of the hepatic extraction ratios in the postabsorptive 
and postcibal states (Table 3) reveals the liver's striking selectivity 
in its handling of arnino acids. While the liver extracted 20-30% of the 
alanine, glycine, and serine presented to it in the basal state, it did 
not significantly extract any of the BCAA. Following ingestion, hepatic 
extraction of the BCAA rose to 6-9% and that of the glucogenic arnino 
acids rose 6-13% above basal. Clearly, increased substrate delivery is 
one determinant of hepatic extraction. The influence of glucagon and 
insulin, both of which rose significantly after protein ingestion (see 
below), on hepatic amino acid extraction is uncertain. Although Brock¬ 
man et al (41) have demonstrated a stimulatory effect of glucagon on he¬ 
patic alanine extraction in sheep, the studies of Jennings et al (26) in 
dogs and Chiasson et al (43) in man have demonstrated that glucagon 
exerts a purely intrahepatic stimulatory effect on gluconeogenesis but 
has no effect on alanine extraction. Felig et al (15) reported decreased 
splanchnic extraction of alanine in the presence of a rise in insulin 
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levels. Subsequent studies by Chiasson et al (36) in the dog and man 
(37), however, have demonstrated no effect by insulin on the hepatic ex¬ 
traction of alanine. The influence of the route of amino acid adminis¬ 
tration on hepatic extraction is addressed below. 
Wahren et al (20) reported that after protein ingestion in man, net 
splanchnic production and arterial levels of glucose remain essentially 
unchanged. The current studies demonstrate that after protein ingestion 
in the dog, hepatic glucose production rises signficantly and remains 
elevated for 2^ hrs post-ingestion. Determinants of this rise in hepa¬ 
tic glucose production may include the increased delivery of glucogenic 
amino acids, with a resultant rise in hepatic gluconeogenesis, and the in¬ 
creased glucagon levels, with a resultant increase in either gluconeogene¬ 
sis or glycogenolysis. Glucagon, portal concentrations of which rose to 
2i2-fold basal levels after protein ingestion, has been shown in dogs 
(26) to stimulate gluconeogenesis from alanine by regulating its intra- 
hepatic metabolism. The precise fates of the various extracted pre¬ 
cursors cannot be ascertained, however, without the concurrent use of 
tracer techniques, not employed in the present studies. 
Although increments in arterial insulin levels comparable to those 
observed in the current studies have been shown to dramatically inhibit 
splanchnic glucose production (5), the concurrent hyperglucagonemia in¬ 
duced by protein ingestion resulted in a net increase in hepatic and net 
splanchnic glucose production. Results of the present glucose tracer 
studies reveal that peripheral glucose uptake, presumably insulin-media¬ 
ted, exceeded the rise in hepatic glucose production and resulted in a 
slight fall in the arterial glcuose level. These results are consistent 





serves to prevent a more prominent insulin-mediated decline in blood 
glucose after a carbohydrate-free protein meal by stimulating hepatic 
glucose production. 
The current studies also demonstrate that intestinal uptake of glu¬ 
cose rises significantly and persistently after a protein meal. The ex¬ 
tracted glucose may in turn furnish additional carbon substrate for the 
increased intestinal production of alanine in the post-cibal state. 
Finally, the strong correlation observed between the quantities of 
individual amino acids ingested and those recovered in the portal blood 
confirm the earlier studies of Adibi et al (84) which demonstrated that 
there is little mixing of exogenous and intestinal endogenous protein 
after protein ingestion. Adibi et al (84) further demonstrated that the 
process of protein digestion exceeds 4 hrs. Several studies in animals 
(9, 19) and man (20, 76) have since confirmed that the combined processes 
of digestion and absorption exceed 4 hrs. Inasmuch as amino acid absorp¬ 
tion was still ongoing at 180 min, the current studies, employing a free 
amino mixture, demonstrate that the absorptive process alone exceeds 3 
hrs. 
II. Intravenous Studies 
The present studies clearly document a pivotal role for the splanch¬ 
nic tissues in the metabolism of parenterally administered amino acids. 
During the high-dose amino acid infusion, there was no significant change 
in the handling of the glucogenic amino acids by the intestinal tissues. 
For the duration of the infusion, these tissues continued to produce ala¬ 
nine and glycine at rates similar to those observed in the postabsorptive 
state (Figure 8). Hepatic removal of these amino acids was dramatically 
increased, however (Figure 8). Over the 3 hr study, the liver removed 
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these amino acids in quantities which equalled or exceeded the adminis¬ 
tered doses (Table 8). Both the hepatic and intestinal tissues remove 
significant quantities of BCAA during the infusion. Of the 2638 ymoles/ 
kg of BCAA administered, the hepatic and intestinal tissues removed 
536±147 ymoles/kg and 436±162 ymoles/kg, respectively, and together 
accounted for the disposal of 37% of the infused load of these amino 
acids. Following amino acid ingestion, the liver alone removed 36% of the 
administered BCAA load. 
During the 3 hr low-dose infusion, the liver similarly removed 
quantities of glucogenic amino acids equal to or greater than the ad¬ 
ministered doses of these amino acids. Despite this, during both the 
low-dose and high-dose infusion, arterial concentrations of the gluco¬ 
genic amino acids rose, reflecting continued net peripheral production 
of these amino acids. The liver removed 36±4% of the total BCAA load 
infused over the 3 hr low-dose study. 
Analysis of the cumulative hepatic, extrahepatic splanchnic, and 
splanchnic balances during the high-dose infusion (Table 8) reveals that 
over the 3 hr study, a total of 10,488 ymoles/kg of amino acids were in¬ 
fused while the splanchnic bed took up only 9229 ymoles/kg. Thus, 1259 
ymoles/kg*3 hr or 7 ymoles/kg‘min of amino acids (largely BCAA) were 
presumably metabolized by peripheral tissues. By comparison, after oral 
(R) intake of the Freamine' ' mixture, there was a net flux of approximately 
5 ymoles/kg*min from the peripheral to the splanchnic tissues. The in¬ 
adequacy of the muscle nitrogen repletion provided by the BCAA during 
high-dose infusion is apparent if one recognizes that, in the postabsorp- 
tive state, there is an average flux of amino acid nitrogen of 6.2 
ymoles/kg*min from peripheral to splanchnic tissues. During the 3 hr in- 
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fusion, then, the quantity of BCAA extracted by the peripheral tissues 
can replete nitrogen stores lost during only 3^^ hrs of fasting. Thus, 
amino acids, whether administered orally or intravenously, do not ade¬ 
quately replenish muscle nitrogen. Some as yet unidentified nitrogen 
carrier, not measured in this and other studies (19, 20, 76), must then 
serve to maintain muscle nitrogen stores in the animal and man. 
The hepatic extraction ratios for the BCAA and the glucogenic amino 
acids rose substantially during both the high-dose and low-dose infusions 
(Table 7), as they did following oral ingestion of amino acids. The mean 
hepatic extraction ratios for all amino acids were strikingly similar 
following oral, low-dose intravenous, and high-dose intravenous amino 
acid administrations (Figure 13). In addition, the mean hepatic extrac¬ 
tion ratios for the peripherally and mesenterically administered low- 
dose infusions were strikingly similar. Thus, it appears that the quan¬ 
tity of substrate delivered rather than the route of administration is 
the major determinant of hepatic amino acid extraction. Bloomgarden et 
al (19) found a strong correlation between intestinal release and hepa¬ 
tic uptake of amino acids and postulated the existence of a mechanism, 
the me diators of which are not as yet identified, which tightly couples 
these two processes. The present studies ^ militate against the 
existence of this link between hepatic and intestinal tissues, since oral and in¬ 
travenously administered amino acids were extracted in nearly identical 
proportions. Although both insulin and glucagon rose during the low-dose 
infusions and quite strikingly during the high-dose infusions (Table 12), 
the influence of these increases in hormonal levels on hepatic amino acid 
extraction is questionable (see above). In addition, levels of both hor¬ 
mones were significantly higher during the high-dose infusions than during 
the low-dose infusions and following oral amino acid administration, yet 
I 
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the mean hepatic extraction ratios in all 3 groups were nearly identi¬ 
cal, arguing against the importance of hormonal levels as determinants 
of hepatic amino acid extraction. 
The effect of parenterally administered amino acids on glucose me¬ 
tabolism was very similar to that observed following amino acid ingestion 
As after amino acid ingestion, hepatic glucose production and net splanch 
nic glucose output rose following low-dose and high-dose amino acid infu¬ 
sions. The magnitude of the rise in hepatic glucose production was 
greater during the high-dose infusions than during the low-dose infusions 
and following ingestion of amino acids. As after oral administration, 
hihg-dose amino acid infusions resulted in a rise in the rates of appear¬ 
ance, disappearance and metabolic clearance of glucose (Figure 11). The 
rate of disappearance rose to a greater extent than the rate of appear¬ 
ance, resulting in a significant decline in plasma arterial glucose lev¬ 
els. Here, too, it is presumed that aminogenic hyperglucagonemia pre¬ 








Mean balances of 5 glucogenic amino acids in the postabsorp- 
tive state (shaded bars) and for the three hour postcibal 
period (open bars) across the extrahepatic splanchnic (upper 
panel), hepatic (middle panel) and splanchnic (lower panel) 
areas. Each bar represents the mean ±1 SEM, Asterisks in¬ 
dicate significant differences between basal and postcibal 
values ***P<0.01. 
Mean balances of leucine, isoleucine, valine, and combined 
branched chain amino acids in the basal state (shaded bars) 
and for the three hours following amino acid ingestion (open 
bars) across the extrahepatic splanchnic (upper panel), he¬ 
patic (middle panel) and splanchnic (lower panel) areas. 
Each bar represents the mean ±1 SEM. Asterisks refer to 
comparison of postabsorptive and postcibal values (*P<0.05, 
***P<0.01). 
Upper panel: Plasma glucose concentrations in the hepatic 
vein (H.V. -0-), artery (A -©-), and portal vein (P.V. -a-) 
in 9 dogs measured in the basal state and for 3 hours fol¬ 
lowing amino acid ingestions, (error bars indicate 1 SEM.) 
Lower panel: Hepatic plasma flow during the basal state 
and following amino acid ingestion. 
Extrahepatic splanchnic (upper panel), hepatic (middle panel), 
and splanchnic (lower panel) glucose balance in the post- 
absorptive state (broken line) and for 3 hours following 
amino acid ingestion. The broken line indicates the basal 








values significantly different than basal (*P<0.05, **P<0.02). 
Error bars indicate 1 SEM. 
The systemic rate of glucose appearance (upper panel), rate 
of disappearance of glucose (middle panel) and metabolic 
clearance rate (lower panel) of glucose in 4 dogs in the ba¬ 
sal state (broken line) and after amino acid ingestion. 
Asterisk indicates values different than basal (P 0.05). 
Error bars indicate 1 SEM. 
Concentrations of insulin and glucagon in portal plasma from 
9 dogs (mean ±SEM) in the postabsorptive state and following 
amino acid ingestion. Values significantly different that 
postabsorptive *P<0.04, **P<0.02. 
The mean (±SEM) extrahepatic splanchnic (upper panel), hepa¬ 
tic (middle panel) and splanchnic (lower panel) balances for 
each of three branched chain amino acids and for total BCAA 
in the postabsorptive state and during amino acid infusion. 
Significant differences between balances in the postabsorp¬ 
tive and amino acid infusion periods are indicated by aster¬ 
isks )(0.05>P^,1, **P<0.05, ***P<0.02). 
The mean (±SEM) extrahepatic splanchnic (upper panel), hepa¬ 
tic (middle panel) and splanchnic (lower panel) balances for 
5 glucogenic amino acids during the 30 min basal period and 
the 3 hours of high dose amino acid infusion. Asterisks 
(****) indicate significant differences (P<0.,01, paired t-test) 




Figure 9: Upper panels: the mean (±SEM) plasma glucose concentration 
in the hepatic vein, artery, and portal vein in the basal 
state and for 3 hours following low dose (left side) on high 
dose (right side) amino acid infusion. Lower panel: mean 
(±SEM) hepatic plasma flow during low dose (left panel) and 
high dose (right panel) amino acid infusion. 
Figure 10: The mean (±SEM) extra hepatic splanchnic (upper panel), hepa 
tic (middle panel), and splanchnic (lower panel) glucose 
balances in the basal state and during 3 hours of low dose 
(left) or high dose (right) amino acid infusion. Asterisk 
indicates values significantly (p=0.05 or less) different 
than postabsorptive value shown by the broken line. 
Figure 11: The systemic rates of glucose appearance (upper panel), 
disappearance (middle panel), and metabolic clearance (lower 
panel) in 4 dogs in the basal state (broken line) and during 
the 3 hours of high dose amino acid infusion. Asterisk in¬ 
dicates values different than basal (p<0.05). Error bars 
indicate 1 SEM. 
Figure 12: The mean (±SEM) hepatic balances for 4 glucogenic amino 
acids (upper panel), and for the individual and combined 
branched chain amino acids (lower panel) in the basal state 
and during the 3 hours of low dose infusion. Significant 
differences between balances in the postabsorptive and amino 
acid infusion periods are indicated by askerisks (*P<0.05, 
**P<0.02, ***P<0.01). 
Figure 13: The mean (+SEM) of the hepatic extraction ratios of four 
glucogenic amino acids (upper panel), and of the individual 
: 'flip i'' 
55 
and combined branched chain amino acids (lower panel) ob¬ 
tained during the three hours following amino acid ingestion 
in 9 dogs (open bars), or during the last two hours of either 
low dose (five dogs, hatched bars) or high dose (five dogs, 
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Hepatic extraction ratio for various amino acids in the basal state and 
following ingestion of an amino acid mixture. 
Amino acid ■Hepatic extraction ratio 
( % ) 
Basal Post-feeding 
P value i 
Alanine 31 + 5 * 37 ± 3 n.s. 
Glycine 22 + 4 * 32 ± 4 <0.025 
Proline 12 + 9 25 ± 4 <0.05 
Serine 29 + 4 * 35 ± 4 0. l>p>0.05 
Leucine - 1 + 2 9 ± 3 <0.05 
Isoleucine - 3 + 3 6 ± 3 0. l>p>0.05 
Valine 0 + 2 6 ± 2 <0.05 
Total BCAA - 1 + 2 6 ± 3 <0.05 
* significantly different from zero at the ]% level of significance or less. 
i refers to comparison of mean basal vs. mean postcibal extraction ratio in 




Cumulative splanchnic, hepatic 
of 9 amino acids over 3 hours 
and extrahepatic splanchnic 












Alanine 580 891±142 1736±166 - 853±118 
Serine 415 279±67 677±66 - 404±45 
Glycine 1958 266±189 2523±260 -2271±185 
Phenylalanine 253 33±25 189±36 - 223±33 
Proline 719 -5±75 693±124 - 683±99 
Tyrosine 0 19±10 16±10 - 4±9 
Valine 416 -144±72 174±86 - 316±48 
Leucine 512 -256±78 192±88 - 448±61 
Isoleucine 390 -188±56 101±67 - 290±41 
Total amino acid 
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Table 7 - Hepatic extraction ratio for amino acids in the 
postabsorptive state and during the last 2 hours 
of high-dose amino acid infusion . 
Amino Acid Hepatic Extraction Ratio 
% 
P value 
(postabsorptive vs infusion) 
Postabsorptive Infusion 
Alanine 35±6 44±3 n.s. 
Glycine 27±4 39±3 n.s. 
Proline 11±4 24±5 < 0.02 
Serine 24±6 36±2 0.10 > P >0.05 
Leucine -3±2 7±1 < 0.05 
Isoleucine -7±3 5±1 < 0.05 
Valine 1±4 7±1 n.s. 




Cumulative splanchnic, hepatic and-extrahepatic splanchnic 
disposal of glucogenic and branched chain amino acids 
during high dose infusion in 5 dogs. 
Amino Acid 
Dose Splanchnic Hepatic 
Extrahepatic 
Splanchnic 
Administered Balance Balance Balance 
pmoles/kg 3h 
★ 
Alanine 1160 1995±299 2364±366 -410±91 
Glycine 3916 4028±668 4329±680 -301±58 
Phenylalanine 506 383±25 432±30 -59±38 
Serine 830 1004±35 945±53 58±39 
Proline 1438 839±76 917±110 -78±121 
Tyrosine 0 10±15 3±12 4±21 
Total glucogenic 
amino acids 
7850 8256±1007 9090±970 -782±222 
Leucine 1026 315±58 167±54 147±25 
Isoleucine 780 197±56 91±33 106±54 
Valine 832 460±156 278±65 183±105 
Total BCAA 2638 973±253 536±147 436+162 




Rate of continuous infusion of 14 individual amino acids 
during low-dose infusion 










* Lysine 1.80 
* Methionine 1.28 
* Tryptophan .27 
* Arginine .76 
* Histidine .66 
* Blood levels of these amino acids not measured. 
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TABLt 10: Cumulative hepatic amino acid uptake during 






% of administered 
removed by liver 
ymoles/kg 3 hrs 
Alanine 580 1542±193 266±33 
Glycine 1958 2086±175 109±8 
Phenylalanine 253 256±30 10U12 
Proline 719 925±260 128±35 
Tyrosine 0 50±19 





513 199±24 39±5 
390 108±14 28±4 
416 165±26 40±6 
1319 472±52 36±4 Total BCAA 
1 
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TABLE 11: Portal plasma insulin arrd glucagon concentrations in the 
postabsorptive state and during amino acid infusion. 
Low dose Amino Acids High dose Amino Acids 
Insulin G1ucagon Insulin Glucagon 
yU/ml pq/ml yU/ml pq/ml 
Basal 35±5 217+78 35±3 162±40 
+ 30 min 47±10 331±130 121±19** 
icic 
540±n0 
+ 60 46±15 363±120* 54±14 530±130* 
+ 90 60±18 418±155 60±8* 490±140 
+ 120 49±18 403±167 72±20 520±150* 
+ 150 31±6 361±195 82±15* 590±170* 
+ 180 32±12 362±192 53±16 500±190 
Significant differences from basal values are indicated by 
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